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Current perspectives of oncoplastic breast surgery in Pakistan
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Abstract
Oncoplastic breast surgery is based on the concept of
tumour-specific immediate reconstruction. It combines
both local and distant techniques to maintain breast
texture, symmetry and cosmesis without compromising
oncological outcome. The current narrative review was
planned to highlight the current state and future of
oncoplastic breast surgery in low- and middle-income
countries where its utilisation in surgical practice remains
insubstantial because majority of the surgeons who are
treating breast cancer are either general surgeons or
breast surgeons who do not have expertise in oncoplastic
breast surgery or reconstructive surgery. Moreover,
scarcity of financial resources, ignorance about
oncoplastic breast surgery techniques, disfigurement
distress and cultural taboos coerce women to hide in the
shadows with their breast disease. Oncoplastic breast
surgery needs more exposure in a developing country like
Pakistan. There is a need to establish dedicated
oncoplastic breast surgery training centres, fellowship
programmes, workshops, and webinars to incorporate
such techniques in the practice of breast surgeons.
Keywords: Oncoplastic surgery, Reconstruction, Low and
middle-income countries, Breast cancer, Breast
conserving surgery.

difference in terms of local recurrence and overall
survival.3,4 In 1993, the term 'oncoplastic' was first
mentioned at the Santa Fe Symposium of Breast Surgery
and Body Contouring. Few years later, its founding
principles were explained in a published article.5 Since
then, OPS has seen rapid and consistent development as
a competitive medical practice for breast surgeons,
making great progress and getting acceptance among
patients and medical society.
Originally developed to aid in the management of
complex tumour sites within the breast, the word
'oncoplastic' explains itself by performing tumouradapted oncological safe procedures along with
cosmetically outstanding breast reconstructions. OPS
covers the technique and art of tumour-specific
immediate breast reconstruction applicable to BCSs as
well as in conservative mastectomy. In this sense, OPS has
the potential to deal with very complex breast cancer
patients by providing the surgeon a wide spectrum of
medical tools, surgical techniques and back-up plans.
Handful of original and review articles have been present
in literature, focussing on the rapidly gaining popularity
of OPS techniques in developing countries.6 The current
narrative review was planned to highlight the prevailing
state and future of breast OPS in low- and middle-income
countries (LMICs).
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Methods and Results

Introduction

The narrative review was conducted at the Department of
Breast Surgery, Aga Khan University Hospital (AKUH),
Karachi, and comprised extensive literature search on
PubMed and Google Scholar databases from the
inception of the databases till June 2021 to explore all
published original and review articles on OPS practices
worldwide, especially in LMICs. Various combinations of
the following terms were utilised during literature search:
"Oncoplastic breast surgery", "Oncoplastic breast
conserving surgery in Low-Middle income countries",
"Oncoplastic techniques", and "Cosmetic outcomes of
oncoplastic breast surgery".

The first registered description of an attempt to reduce a
female breast was by the Will Duston in 1670.1 Two
centuries later, in 1882, T. Gaillard Thomas from New York
was the first one to integrate an incision at the mammary
sulcus and reduce a breast with the intention to excise a
benign tumour.2 Oncoplastic surgery (OPS) of the breast
began its journey around the mid-1970s as reductive
techniques started to be performed expeditiously for
breast cancer patients. It was also at this time when the
first data from the Milan trial comparing breastconserving surgery (BCS) together with radiotherapy (RT)
and traditional Halsted mastectomy showed no
1,3-6Aga
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Research articles published in languages other than
English, duplicate publications and studies with
incomplete data were excluded. Of the 300 articles
identified, after consensus between two independent
reviewers, 21(7%) were selected for detailed review.
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Discussion
The current review in the first from Pakistan addressing
OPS breast conservation in a country that has a much
higher incidence of breast cancer with many presenting
with bigger tumour sizes.
OPS and new surgical possibilities: OPS was conceived
to provide surgical techniques to treat very complex
breast lesions. Large tumours with unfavourable
anatomic localisations have always been a challenge in
the treatment of breast cancer patients and there has
been concerns regarding the oncological safety of
surgical procedures without sacrificing cosmetic
outcome. It is known that up to 30% of the women
undergoing BCS will have a residual deformity amenable
for cosmetic correction.7
Other complex clinical scenarios, such as breast cancer in
patients with prosthetic breast augmentation, breast
cancer recurrence with previously irradiated tissues
secondary to breast conserving surgery, and patients with
substantial deformities, are part of daily practice and are
perfectly addressed by surgeons who have the
knowledge and skills to perform OPS (Table-1).8 There
should be awareness that OPS is not a one-size-fits-all
system and efforts should focus on individual oncological
treatment protocols. Considerations regarding the
relative size and tumour location, the anatomy of the
breast and body, as well as patients' preference have all to
be balanced to fulfil patient needs.
Local and distant control of the disease, improvement in
overall survival, and quality of life, are primary endpoints
in the care of breast cancer patients. The oncological
intervention from the surgical point of view should always
be in line with international standards regarding tumour
management, resection margins, lymph node staging,
pathology interpretation and processing of the tumour
specimen. Special attention should be taken to cut down
re-excision rates as much as possible, as this issue has
great psychological impact on patients besides the
additional costs.9,10
Table-1: Complex breast cancer patients managed by oncoplastic surgeons.
Breast cancer recurrence
Breast cancer in augmented patients
Previously radiated breast and skin tissue
History of lymphoma, mantle radiation to the thorax and secondary breast cancer
Breast cancer during pregnancy
BRCA Mutation
Aggressive tumour biology (i.e., triple negative, high grade tumors, etc)
Patients with heart pacemakers
High degree of distortion and asymmetry from previous surgery and radiotherapy
BRCA: Breast cancer gene A.
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Figure: Principles to obtain a naturally shaped reconstructed breast.

Once the oncological procedure has been accomplished,
the reconstructive phase begins, and it is at this point that
the OPS becomes the best intervention to provide
patients a functional and good quality of life. In the
process of breast reconstruction, a complete
understanding of the breast shape in a three-dimensional
(3D) conception is needed.
There are multiple reconstructive options available to
restore symmetry in BCS. They can be divided into three
broad categories: volume displacement techniques using
available gland parenchyma, fat, and skin to remodel and
redistribute tissue; volume replacement techniques to fill
up spaces with both local or distant flaps; and volume
reduction techniques in cases when ptosis and volume
improve as well. Either with the use of local or distant
flaps, and autologous or prosthetic tissue, the success of
the reconstruction is based on surgical principles of a
meticulous tissue handling. Basic aspects of adequate
blood supply to tissues, integration of scars from previous
surgery, precise flap positioning and rotation, and
tension-free closure, should be on the checklist to ensure
a successful result. The final touch in "sculpturing and
tailoring" tissues can be a true artistic challenge. Getting
all the pieces together for the precise volume and
projection, the accurate lateral flow and infra-mammary
fold, will result in a naturally shaped and anatomic
reconstructed breast5 (Figure).
The essence of a competitive OPS clinical practice relies
on surgical precision planning which means having a
detailed and meticulous surgical workup for each patient.
OPS worldwide: OPS is being practised worldwide and
the facility is available at most recognised breast cancer
centres around the world. It is known that the quality of
treatment and medical attention can be substantially
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improved through specialisation, certification and
external monitoring of breast cancer centres.11
Breast units are also associated with increased economic
efficiency secondary to tight organisational structures,
simplified patient routing, common purchasing and, to
some extent, to the avoidance of multiple examinations.12
The logistics and requirements to perform OPS can be
pragmatically integrated processes practised at breast
centres and hospitals. It is important to say that
specialised breast cancer units are expected to oversee a
large volume of cases. It has been calculated that an
increase from 50 to 100 new breast cancer cases per year
results in almost 50% reduction of average costs in the
management of these patients.13 This can be of particular
interest to health systems with a limited budget
struggling to find a way to optimise healthcare for breast
cancer patients.
Certified OPS breast centres should be able to provide a
clear and efficient network of care. Strong interdisciplinary
work is a key for success in the treatment of these patients,
and feedback is needed from all the involved medical
fields, including surgery, medical oncology, radiotherapy,
psychology and specialised nursing.
Prevailing state of OPS in LMICs: OPS has successfully
made its way into LMICs over the past two decades and
has become an effective surgical intervention of choice
for women presenting with an early stage of breast
cancer, complex anatomic locations, or non-responding
disease to neo-adjuvant treatment. Data-driven evidence
has also validated the expeditiously increasing popularity
of OPS in LMICs.6,14,15
In Pakistan, a developing country, OPS is still in its nascent
state associated with less popularity possibly because of
factors related to patients and surgeons.16 Patient-related
factors may include underlying issues of low
socioeconomic status, psycho-social taboos, false
assumptions that mastectomy is associated with better
survival, reliance on alternative therapies and lack of
awareness of oncoplastic techniques. The surgeonrelated factors may include paucity of training and
education programmes in breast OPS that affect the
decision-making process of surgeons, while many also
believe that training in OPS might hinder their
performance as an oncological surgeon.17 Majority of the
surgeons who are treating patients happen to be either
general surgeons or breast surgeons with no expertise in
OPS or reconstructive surgery. Many patients do not opt
for OPS when they are advised to follow two surgeons
separately for oncological and aesthetic part of the
surgical procedure, and lack of OPS multidisciplinary
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team meetings also results in compromised cosmetic
outcome as incisions or dissections performed by
oncological surgeons are often either hamper the
cosmetic outcome or require more complex procedure to
maintain cosmesis. In private setups, patients usually
choose the cost-effective procedure, which is a simple
BCT or mastectomy, and none of the government
hospitals in Pakistan has any trained Oncoplastic Surgeon.
One of the biggest cancer institutions in Lahore has
adequately trained OPS surgeons, but they do not offer
level III OPS techniques or reconstruction to reduce
operative cost. Compromised access to education and
healthcare facilities, weak financial status because the
majority of females are not earning members of their
families, and religious reasons also contribute to surgical
planning and decision. Breast cancer patients do not have
much awareness about breast conservation, as females
are hesitant to discuss available surgical portfolio for their
disease with male surgeons where OPS/female surgeons
are not available. Therefore, they drop the idea of any
form of partial or total breast reconstruction.
Data published by a trained oncoplastic surgeon from
Pakistan showed that patient acceptability and outcome
improved when procedures were offered to suitable
candidates, with promising cosmetic outcome and lesser
complications which not only resulted in sharp decline in
mastectomy rates among the young and the middleaged, but also in the rate of re-excision with improved
quality of life.16,18
The situation is much better in neighbouring India where
there is a dedicated OPS centre and trained eminent OPS
surgeons ensuring that the field is evolving fast despite
the shortcomings. A structured training course has also
been initiated, incorporating all the breast oncoplastic
surgeons from India and the United Kingdom to provide
detailed training of OPS principles and techniques.
Surgical simulations, live mark-up sessions, workshops
and doing operative interventions under the supervision
of well-trained oncoplastic surgeons from across the
globe helps in providing hands-on training to aspiring
breast surgeons.15
The status and trends of breast OPS in other LMICs cannot
be discerned as there is a paucity of published data.6 The
need of the time is to have One Oncoplastic Breast
Surgeon-Dual Role Model. Essentially this is a more
acceptable model as dual cost can be saved, the patient
does not need to pay to two surgeons, one surgeon can
handle both oncological and aesthetic aspects of the
case, and provide better care and cosmetic outcome.19
The future of OPS: The future of OPS depends on further
Vol. 72, No. 1 (Suppl. 1), January 2022
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Table-2: International Oncoplastic breast surgery (OPS) fellowship programmes.
Country / City
Dusseldorf, Germany
Milan, Italy
London, Great Britain
Barretos, Brazil
Paris, France
Pune, India

Hospital Breast Center

Program Director

Marien Hospital Breast Center
Istituto Europeo di Oncologia
Royal Marsden Hospital
Oncoplastic Training Center
The Paris Breast
Centre-L'Institut du Sein
Orchids Breast Health Clinic

Prof. Werner Audretsch
Prof. Mario Rietjens
Miss. Fiona McNeill
Dr. Gustavo Matthes
Dr. Krishna Clough
Dr. C. Koppiker

medical innovations in breast cancer treatment and the
dissemination of its founding basis and principles to the
new generations of breast surgeons. This can only be
accomplished through the development of competitive
and formal training fellowship programmes for the
specialisation of human resource in the OPS field.
Several fellowship programmes have been established
worldwide and are committed with high standards of
academic and practical training. Some international OPS
fellowship programmes are more recognised than the
rest (Table-2).
Although OPS training has had great impact on the
specialisation of young breast surgeons, some challenges
need to be faced and overcome. Important areas to be
developed in OPS include a license approval on a global
level, and the creation of an international committee to
regulate adapted practice standards across different
countries.
Most surgeons start practising oncoplastic techniques
after attending few courses, which does compromise the
aesthetic outcome with complications. Taking a single
workshop on OPS training does not make one an expert in
the technique. It is a journey, not a single course, which
slowly and steadily needs to be integrated in one's
practice. After all, mastery needs practice.20
In terms of limitations, published papers on the indexed
search engines from LMICs are rather old, and, therefore, the
references included in the current review are not recent.

mandatory. Ultimately, OPS is committed to providing the
highest standard of care for breast cancer patients,
making its future always very promising. Oncoplastic
surgery can bring favourable change to surgical aspect of
breast cancer management in LMICs by increasing the
rate of breast conservations, reducing cost and workload,
with lesser rate of re-excisions in already overburdened
healthcare systems. There is a need to overcome the gap
in practices between the developed and the developing
worlds, and to train surgeons in this regard from
developing countries.
Disclaimer: None.
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